Skip to main content
Clinical Trials/NCT05197946
NCT05197946
Recruiting
N/A

Anatomical and Functional Imaging Correlates of Chronic Pain in Cerebral Palsy

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.4 sites in 1 country300 target enrollmentDecember 4, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cerebral Palsy
Sponsor
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Enrollment
300
Locations
4
Primary Endpoint
Regional brain/spine volumes
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

The investigators hope to use MRI biomarkers to identify and characterize sensorimotor network disruption patterns associated with chronic pain and sensory deficits in CP. Investigators will use existing information in the medical record as well as subjective reports from interview, physical exam data, and anatomical and functional MRI data to non-invasively identify brain injury correlates of pain and sensory deficits.

Detailed Description

Background: Seventy percent of adults with cerebral palsy (CP) have chronic pain. Patterns in pain symptoms suggest that different individuals have different types of pain. People with CP have differences in brain structure and function, but links with pain mechanisms are not well-understood. Better understanding could help inform precision diagnosis and management of pain subtypes in individuals with CP. Objectives: Primary: Identify and characterize sensorimotor network disruption patterns associated with chronic pain and motor deficits in CP Secondary: * Improve understanding of anatomical brain network changes in CP associated with sensory deficits and pain * Identify non-invasive imaging-based neurobiomarkers applicable to sensory loss and pain in CP Procedures: Standardized online questionnaires: Participants (individuals with CP, controls, and/or caregivers) are first asked to complete standardized questionnaires reviewing pain symptoms, demographics, and medical history (CP-related and more generally). Online questionnaires replaced Structured Interview and Physical Examination procedures at the onset of COVID safety restrictions. Review of medical records: For consenting individuals, medical records will be requested and reviewed by the research team. Previously-acquired traditional MRI obtained for clinical purposes will be requested and reviewed to detect correlation between routine neuroimaging markers of perinatal brain injury and CP and pain. If of suitable quality, quantitative analysis methods (e.g. analysis of brain lobe and ventricular volumes for volumetric anatomical sequences, analysis of white matter volumes from DTI sequences) may be applied to prior images. MRI: Research unsedated MRI scans (outside of usual care) will be performed using a 3T Philips scanner at the F.M. Kirby Research Center. An MRI scanning protocol will be at the F.M. Kirby Research Center; the protocol will not last more than 1.5 hours. Acquisitions will include a triplanar survey, functional and anatomical multi-slice imaging of the brain as well as MRI of selected spinal levels. Protocols will be used that do not involve use of contrast agents and limit power/tissue absorption as well as otherwise remain within FDA and Kirby Center safety regulations. When possible, MRI will be performed within 3 months of initial survey/interview administration. If MRI is scheduled \>3 months after initial survey/interview administration, a brief survey will be re-administered to screen for changes in pain/clinical status.

Registry
clinicaltrials.gov
Start Date
December 4, 2018
End Date
April 7, 2026
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Individual 8+ years of age
  • Diagnosis of cerebral palsy

Exclusion Criteria

  • Neurotypical participants: (Survey-only):
  • Inclusion Criteria:
  • Individual 8+ years of age
  • Adult subject able to indicate understanding and affirmative consent OR Adult/child subject unable to indicate understanding and affirmative consent AND subject assents AND LAR consents
  • Exclusion Criteria:
  • Clinically-significant neurologic or developmental diagnosis
  • Participants with CP (Survey and MRI):
  • Inclusion Criteria:
  • Individual 8+ years of age
  • Adult subject able to indicate understanding and affirmative consent OR Adult subject unable to indicate understanding and affirmative consent AND subject assents AND LAR consents

Outcomes

Primary Outcomes

Regional brain/spine volumes

Time Frame: <3 months

Regional volumes will be measured using MR processing software

Diffusion scalars

Time Frame: <3 months

Diffusion scalars for tracts of interest including the posterior thalamic radiations as well as somatosensory association fibers and the spinothalamic tract

Study Sites (4)

Loading locations...

Similar Trials